13F HOLDINGS REPORT (Amended)
Eversept Partners, LP
Quarter ended Q4 2023 · Filed November 8, 2023 · Accession 0001697013-23-000007
Total Value
$215.3M
Positions
57
Other Managers
0
Confidential Omitted
No
Holdings (57)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | QUALITY CARE PPTYS INC | 747545101 | 1,030,661 | $20.0M | 9.30% |
| 2 | SPDR S&P 500 ETF TR | SPY | 60,000 | $15.8M | 7.33% |
| 3 | R1 RCM INC | 749397105 | 1,909,887 | $13.6M | 6.33% |
| 4 | RADIUS HEALTH INC | 750469207 | 333,738 | $12.0M | 5.57% |
| 5 | AERIE PHARMACEUTICALS INC | 00771V108 | 210,778 | $11.4M | 5.31% |
| 6 | ABLYNX NV | 00372Y105 | 181,891 | $9.9M | 4.61% |
| 7 | AVEXIS INC | 05366U100 | 78,201 | $9.7M | 4.49% |
| 8 | ALNYLAM PHARMACEUTICALS INC | ALNY | 78,893 | $9.4M | 4.36% |
| 9 | GLAXOSMITHKLINE PLC | GLAXF | 226,584 | $8.9M | 4.16% |
| 10 | ARENA PHARMACEUTICALS INC | 040047607 | 220,788 | $8.7M | 4.05% |
| 11 | ENSIGN GROUP INC | ENSG | 325,897 | $8.6M | 3.99% |
| 12 | ZOGENIX INC | 98978L204 | 204,546 | $8.2M | 3.80% |
| 13 | VERTEX PHARMACEUTICALS INC | VRTX | 44,822 | $7.3M | 3.39% |
| 14 | ARRAY BIOPHARMA INC | 04269X105 | 357,727 | $5.8M | 2.71% |
| 15 | SANOFI | SNYNF | 137,972 | $5.5M | 2.57% |
| 16 | NEVRO CORP | 64157F103 | 60,850 | $5.3M | 2.45% |
| 17 | TELIGENT INC NEW | 87960W104 | 1,550,383 | $5.2M | 2.42% |
| 18 | SAGE THERAPEUTICS INC | 78667J108 | 24,000 | $3.9M | 1.80% |
| 19 | BIOMARIN PHARMACEUTICAL INC | BMRN | 46,000 | $3.7M | 1.73% |
| 20 | TESARO INC | 881569107 | 51,523 | $2.9M | 1.37% |
| 21 | ARGENX SE | ARGX | 35,784 | $2.9M | 1.34% |
| 22 | ABBOTT LABS | ABLZF | 47,900 | $2.9M | 1.33% |
| 23 | TG THERAPEUTICS INC | TGTX | 150,000 | $2.1M | 0.99% |
| 24 | ABIOMED INC | 003654100 | 7,094 | $2.1M | 0.96% |
| 25 | MYOKARDIA INC | 62857M105 | 42,000 | $2.0M | 0.95% |
| 26 | INVACARE CORP | 461203101 | 99,902 | $1.7M | 0.81% |
| 27 | DECIPHERA PHARMACEUTICALS IN | 24344T101 | 85,090 | $1.7M | 0.79% |
| 28 | ASCENDIS PHARMA A S | ASND | 24,054 | $1.6M | 0.73% |
| 29 | PUMA BIOTECHNOLOGY INC | PBYI | 22,924 | $1.6M | 0.72% |
| 30 | CARETRUST REIT INC | CTRE | 108,264 | $1.5M | 0.68% |
| 31 | ANTHEM INC | ELV | 6,000 | $1.3M | 0.61% |
| 32 | MEDICINES CO | 584688105 | 39,317 | $1.3M | 0.60% |
| 33 | IOVANCE BIOTHERAPEUTICS INC | IOVA | 65,000 | $1.1M | 0.51% |
| 34 | HAEMONETICS CORP | HAE | 14,646 | $1.1M | 0.50% |
| 35 | CENTENE CORP DEL | CNC | 10,000 | $1.1M | 0.50% |
| 36 | EHEALTH INC | EHTH | 74,546 | $1.1M | 0.50% |
| 37 | EPIZYME INC | 29428V104 | 57,449 | $1.0M | 0.47% |
| 38 | MAGELLAN HEALTH INC | 559079207 | 9,282 | $994,102 | 0.46% |
| 39 | GLOBAL BLOOD THERAPEUTICS IN | 37890U108 | 17,800 | $859,740 | 0.40% |
| 40 | ARENA PHARMACEUTICALS INC | 040047607 | 20,900 | $825,550 | 0.38% |
| 41 | ALIGN TECHNOLOGY INC | ALGN | 3,000 | $753,390 | 0.35% |
| 42 | AMARIN CORP PLC | AMRN | 250,000 | $752,500 | 0.35% |
| 43 | IRADIMED CORP | IRMD | 51,059 | $735,250 | 0.34% |
| 44 | AFFIMED N V | N01045108 | 386,862 | $715,695 | 0.33% |
| 45 | BIOCRYST PHARMACEUTICALS | BCRX | 148,959 | $710,534 | 0.33% |
| 46 | DYNAVAX TECHNOLOGIES CORP | 268158201 | 30,000 | $595,500 | 0.28% |
| 47 | ARBUTUS BIOPHARMA CORP | ABUS | 117,495 | $587,475 | 0.27% |
| 48 | ALBIREO PHARMA INC | 01345P106 | 18,029 | $587,205 | 0.27% |
| 49 | MELINTA THERAPEUTICS INC | 58549G100 | 76,837 | $568,594 | 0.26% |
| 50 | FOAMIX PHARMACEUTICALS LTD | M46135105 | 107,500 | $551,475 | 0.26% |
| 51 | AQUINOX PHARMACEUTICALS INC | 03842B101 | 31,987 | $450,377 | 0.21% |
| 52 | OPHTHOTECH CORP | 683745103 | 149,100 | $408,534 | 0.19% |
| 53 | ENVISION HEALTHCARE CORP | 29414D100 | 9,520 | $365,854 | 0.17% |
| 54 | MIMEDX GROUP INC | MDXG | 48,000 | $334,560 | 0.16% |
| 55 | SEASPINE HLDGS CORP | SE | 30,899 | $313,316 | 0.15% |
| 56 | DERMIRA INC | 24983L104 | 20,018 | $159,944 | 0.07% |
| 57 | QUOTIENT LTD | G73268107 | 10,511 | $49,507 | 0.02% |